Selected research
Industry Research
Bictegravir Industry Research Report 2026
Market perspective
The global Bictegravir market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Bictegravir is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Bictegravir is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Bictegravir is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Bictegravir include Cipla, Gilead Sciences, Hetero Drugs Limited, Laurus Labs, Selleck Chemicals, Changzhou Pharmaceutical Factory, Jiangsu Coben Pharmaceutical, Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical and Shanghai Haoyuan Chemexpress, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Bictegravir market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bictegravir Market by Company
Cipla
Gilead Sciences
Hetero Drugs Limited
Laurus Labs
Selleck Chemicals
Changzhou Pharmaceutical Factory
Jiangsu Coben Pharmaceutical
Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical
Shanghai Haoyuan Chemexpress
Shanghai Systeam Biochem
Shanghai Topscience
ShenZhen HwaGen Pharmaceutical
Bictegravir Segment by Type
97% - 99%
Above 99%
Bictegravir Segment by Application
Hospitals
Clinics
Labs
Bictegravir Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bictegravir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bictegravir and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bictegravir.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bictegravir manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bictegravir by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bictegravir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 97% - 99%
- Above 99%
Applications
- Hospitals
- Clinics
- Labs
Companies covered
- Cipla
- Gilead Sciences
- Hetero Drugs Limited
- Laurus Labs
- Selleck Chemicals
- Changzhou Pharmaceutical Factory
- Jiangsu Coben Pharmaceutical
- Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical
- Shanghai Haoyuan Chemexpress
- Shanghai Systeam Biochem
- Shanghai Topscience
- ShenZhen HwaGen Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Bictegravir Market Size (2021-2032)
- 2.2.2 Global Bictegravir Sales (2021-2032)
- 2.2.3 Global Bictegravir Market Average Price (2021-2032)
- 2.3 Bictegravir by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 97% - 99%
- 2.3.3 Above 99%
- 2.4 Bictegravir by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
- 2.4.4 Labs
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Bictegravir Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Bictegravir Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Bictegravir Revenue of Manufacturers (2021-2026)
- 3.4 Global Bictegravir Average Price by Manufacturers (2021-2026)
- 3.5 Global Bictegravir Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Bictegravir, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Bictegravir, Product Type & Application
- 3.8 Global Manufacturers of Bictegravir, Established Date
- 3.9 Global Bictegravir Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Cipla
- 4.1.1 Cipla Company Information
- 4.1.2 Cipla Business Overview
- 4.1.3 Cipla Bictegravir Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Cipla Bictegravir Product Portfolio
- 4.1.5 Cipla Recent Developments
- 4.2 Gilead Sciences
- 4.2.1 Gilead Sciences Company Information
- 4.2.2 Gilead Sciences Business Overview
- 4.2.3 Gilead Sciences Bictegravir Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Gilead Sciences Bictegravir Product Portfolio
- 4.2.5 Gilead Sciences Recent Developments
- 4.3 Hetero Drugs Limited
- 4.3.1 Hetero Drugs Limited Company Information
- 4.3.2 Hetero Drugs Limited Business Overview
- 4.3.3 Hetero Drugs Limited Bictegravir Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hetero Drugs Limited Bictegravir Product Portfolio
- 4.3.5 Hetero Drugs Limited Recent Developments
- 4.4 Laurus Labs
- 4.4.1 Laurus Labs Company Information
- 4.4.2 Laurus Labs Business Overview
- 4.4.3 Laurus Labs Bictegravir Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Laurus Labs Bictegravir Product Portfolio
- 4.4.5 Laurus Labs Recent Developments
- 4.5 Selleck Chemicals
- 4.5.1 Selleck Chemicals Company Information
- 4.5.2 Selleck Chemicals Business Overview
- 4.5.3 Selleck Chemicals Bictegravir Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Selleck Chemicals Bictegravir Product Portfolio
- 4.5.5 Selleck Chemicals Recent Developments
- 4.6 Changzhou Pharmaceutical Factory
- 4.6.1 Changzhou Pharmaceutical Factory Company Information
- 4.6.2 Changzhou Pharmaceutical Factory Business Overview
- 4.6.3 Changzhou Pharmaceutical Factory Bictegravir Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Changzhou Pharmaceutical Factory Bictegravir Product Portfolio
- 4.6.5 Changzhou Pharmaceutical Factory Recent Developments
- 4.7 Jiangsu Coben Pharmaceutical
- 4.7.1 Jiangsu Coben Pharmaceutical Company Information
- 4.7.2 Jiangsu Coben Pharmaceutical Business Overview
- 4.7.3 Jiangsu Coben Pharmaceutical Bictegravir Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Jiangsu Coben Pharmaceutical Bictegravir Product Portfolio
- 4.7.5 Jiangsu Coben Pharmaceutical Recent Developments
- 4.8 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical
- 4.8.1 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Company Information
- 4.8.2 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Business Overview
- 4.8.3 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Bictegravir Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Bictegravir Product Portfolio
- 4.8.5 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Recent Developments
- 4.9 Shanghai Haoyuan Chemexpress
- 4.9.1 Shanghai Haoyuan Chemexpress Company Information
- 4.9.2 Shanghai Haoyuan Chemexpress Business Overview
- 4.9.3 Shanghai Haoyuan Chemexpress Bictegravir Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Shanghai Haoyuan Chemexpress Bictegravir Product Portfolio
- 4.9.5 Shanghai Haoyuan Chemexpress Recent Developments
- 4.10 Shanghai Systeam Biochem
- 4.10.1 Shanghai Systeam Biochem Company Information
- 4.10.2 Shanghai Systeam Biochem Business Overview
- 4.10.3 Shanghai Systeam Biochem Bictegravir Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Shanghai Systeam Biochem Bictegravir Product Portfolio
- 4.10.5 Shanghai Systeam Biochem Recent Developments
- 4.11 Shanghai Topscience
- 4.11.1 Shanghai Topscience Company Information
- 4.11.2 Shanghai Topscience Business Overview
- 4.11.3 Shanghai Topscience Bictegravir Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Shanghai Topscience Bictegravir Product Portfolio
- 4.11.5 Shanghai Topscience Recent Developments
- 4.12 ShenZhen HwaGen Pharmaceutical
- 4.12.1 ShenZhen HwaGen Pharmaceutical Company Information
- 4.12.2 ShenZhen HwaGen Pharmaceutical Business Overview
- 4.12.3 ShenZhen HwaGen Pharmaceutical Bictegravir Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 ShenZhen HwaGen Pharmaceutical Bictegravir Product Portfolio
- 4.12.5 ShenZhen HwaGen Pharmaceutical Recent Developments
5 Global Bictegravir Market Scenario by Region
- 5.1 Global Bictegravir Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Bictegravir Sales by Region: 2021-2032
- 5.2.1 Global Bictegravir Sales by Region: 2021-2026
- 5.2.2 Global Bictegravir Sales by Region: 2027-2032
- 5.3 Global Bictegravir Revenue by Region: 2021-2032
- 5.3.1 Global Bictegravir Revenue by Region: 2021-2026
- 5.3.2 Global Bictegravir Revenue by Region: 2027-2032
- 5.4 North America Bictegravir Market Facts & Figures by Country
- 5.4.1 North America Bictegravir Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Bictegravir Sales by Country (2021-2032)
- 5.4.3 North America Bictegravir Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Bictegravir Market Facts & Figures by Country
- 5.5.1 Europe Bictegravir Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Bictegravir Sales by Country (2021-2032)
- 5.5.3 Europe Bictegravir Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Bictegravir Market Facts & Figures by Country
- 5.6.1 Asia Pacific Bictegravir Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Bictegravir Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Bictegravir Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Bictegravir Market Facts & Figures by Country
- 5.7.1 South America Bictegravir Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Bictegravir Sales by Country (2021-2032)
- 5.7.3 South America Bictegravir Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Bictegravir Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Bictegravir Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Bictegravir Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Bictegravir Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Bictegravir Sales by Type (2021-2032)
- 6.1.1 Global Bictegravir Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Bictegravir Sales Market Share by Type (2021-2032)
- 6.2 Global Bictegravir Revenue by Type (2021-2032)
- 6.2.1 Global Bictegravir Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Bictegravir Revenue Market Share by Type (2021-2032)
- 6.3 Global Bictegravir Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Bictegravir Sales by Application (2021-2032)
- 7.1.1 Global Bictegravir Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Bictegravir Sales Market Share by Application (2021-2032)
- 7.2 Global Bictegravir Revenue by Application (2021-2032)
- 7.2.1 Global Bictegravir Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Bictegravir Revenue Market Share by Application (2021-2032)
- 7.3 Global Bictegravir Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Bictegravir Value Chain Analysis
- 8.1.1 Bictegravir Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Bictegravir Production Mode & Process
- 8.2 Bictegravir Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Bictegravir Distributors
- 8.2.3 Bictegravir Customers
9 Global Bictegravir Analyzing Market Dynamics
- 9.1 Bictegravir Industry Trends
- 9.2 Bictegravir Industry Drivers
- 9.3 Bictegravir Industry Opportunities and Challenges
- 9.4 Bictegravir Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst